We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1157:HKEXZoomlion Heavy Industry Science and Technology Co., Ltd. Analysis

Data as of 2026-06-22 - not real-time

HK$7.93

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Zoomlion trades at HK$7.93, sitting above its 20‑day SMA (7.71) but below the 50‑day and 200‑day SMAs (≈8.02), indicating a short‑term bounce within a neutral longer‑term trend. Technical indicators are mixed: the MACD histogram is positive and the signal line is bullish, while the RSI of 51 suggests neither overbought nor oversold conditions. Fundamentally, the stock’s trailing P/E of 13.7 is well below the industry average of 31.4, hinting at relative undervaluation, yet the DCF‑derived fair value of HK$5.05 is far beneath the current price, reflecting concerns over negative free cash flow and high leverage (debt‑to‑equity ≈ 66%). The dividend yield of 9.75% is exceptionally high, but a payout ratio of 99.6% and a free cash flow deficit raise questions about sustainability. Recent exposure from the Global Mining Machinery Expo suggests potential upside in the mining equipment segment, complementing modest revenue growth of 6.9% YoY. However, volatility remains elevated at 40% over 30 days and the beta of 0.40 signals limited market sensitivity, while the max drawdown of 31% underscores downside risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD signal
  • High dividend yield but sustainability concerns
  • Price near support level

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued P/E relative to industry
  • Forward EPS guidance improvement
  • Potential demand boost from recent mining expo

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Elevated debt and negative free cash flow
  • Cyclical nature of construction and mining equipment
  • Uncertain dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth6.90%
Profit Margin8.18%
P/E Ratio13.7
ROE7.41%
ROA1.92%
Debt/Equity66.12
P/B Ratio1.0
Op. Cash FlowHK$5.1B
Free Cash FlowHK$-5213478912
Industry P/E31.4

Technical Analysis

TrendNeutral
RSI51.2
SupportHK$7.10
ResistanceHK$8.34
MA 20HK$7.71
MA 50HK$8.02
MA 200HK$8.02
MACDBullish
VolumeStable
Fear & Greed Index91.46

Valuation

Fair ValueHK$5.05
Target PriceHK$9.87
Upside/Downside24.40%
GradeFair
TypeValue
Dividend Yield9.75%

Risk Assessment

Beta0.40
Volatility40.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.